Jerry Bagel
7PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 16, 2026
Efficacy and Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis with Diabetes: Pooled Subgroup Analysis of reSURFACE 1 and reSURFACE 2.Jerry Bagel, Ranga Gogineni, Asif Shaikh
|Sep 16, 2024
Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry.Andrew Blauvelt, Robert R McLean, Silky W Beaty
|Jun 30, 2024
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials.Neil J Korman, Richard B Warren, Jerry Bagel
|Nov 02, 2021
IGAxBSA composite for assessing disease severity and response in patients with atopic dermatitis.A S Paller, J K L Tan, J Bagel
|Aug 05, 2021
Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study.Andrew Blauvelt, April W Armstrong, Richard G Langley
|Oct 13, 2020
Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis.Jerry Bagel, Elise Nelson, James Zapata
Pageof 2
Frequent Collaborators
4 joint publications
Andrew Blauvelt
2 joint publications
April W Armstrong
2 joint publications
Diamant Thaçi
1 joint publications
A S Paller
1 joint publications
J K L Tan
1 joint publications
A B Rossi
1 joint publications
B Shumel
1 joint publications
A Abramova
1 joint publications
Lyn C Guenther
1 joint publications
Carle Paul
